ArticleScientific reports2026
Long-term competition experiments reveal limited adaptive evolution in human cell lines.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Cancer progression is driven by somatic evolution, where mutations and selection generate more adapted clones. However, it remains unclear whether human cells continue to evolve under stable laboratory conditions or instead reach a near-optimal state. We addressed this using two human cell lines, HeLa and 293, with isogenic subpopulations differing only by a fitness-neutral marker (inducible GFP expression). Mixed GFP⁺ and GFP⁻ populations were co-cultured for 12 months under constant conditions, with competition assays performed with or without periodic GFP induction and sorting. In a parallel experiment inspired by Velicer's microbial studies, GFP⁺ cells were exposed to independently cultured, non-evolving GFP⁻ populations to test whether competitively advantageous variants could emerge when competitors could not respond. Initially, we observed patterns consistent with genetic drift, followed by a gradual expansion of GFP⁻ cells. After 4-6 months, a likely beneficial mutation in the GFP⁺ 293 population reversed this trend, whereas GFP⁻ HeLa cells retained their advantage. Fitness differences were small, and observed dynamics were consistent with weak selection. These results suggest that long-term cultured human cells evolve slowly without rapid clonal expansion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.